News Spotlight : Latest Podcast

Leading the Shift Towards Value-Based Care with Atrius Health CEO Dr. Steve Strongwater

Atrius Health is way ahead of the curve when it comes to risk-based reimbursement models. With 715 doctors providing care to approximately 745,000 patients, Atrius Health has quickly grown ...

LISTEN ON ITUNES LISTEN ON SPOTIFY

News Spotlight : Latest News

David Macdonald to Present at BIO Investor Forum

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s President & CEO, David Macdonald will be among the presenters at the 2019 BIO Investor Forum.

READ THE FULL ARTICLE

News

LRVHealth

  • In Episode 8 of “Healthcare is Hard: A Podcast for Insiders,

    In the latest episode of Healthcare is Hard: A Podcast for Insiders, Keith J. Figlioli talks to Atrius Health CEO Steven Strongwater about how his organization is leading the shift to value-based care and now derives nearly 80% of its revenue from full-risk contracts. Listen here: https://lnkd.in/e4V5CKp

  • AI as a tool for healthcare is promising, but the relationship isn't yet fully realized. We ask: what are the main challenges to AI adoption in healthcare?

    LRVHealth's Keith J. Figlioli shared a few thoughts with Disruptor Daily about the challenges the healthcare industry will face with AI adoption:

  • In Episode 8 of “Healthcare is Hard: A Podcast for Insiders,

    About 95% of contact with patients takes place in the out-patient setting, but it’s extremely hard for them to navigate. Through personal experience Terry Shaw knows this as well as anyone, and as president and CEO of AdventHealth, he’s forging a path for change. Learn more on Episode 10 of the Healthcare is Hard Podcast with Keith J. Figlioli.

Follow

LRVHealth and Portfolio News

October 16, 2019
David Macdonald to Present at BIO Investor Forum

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s President & CEO, David Macdonald will be among the presenters at the 2019 BIO Investor Forum.

Read Full Article >
October 15, 2019
Censinet Announces the Appointment of Independent Board Member

Censinet, the third-party risk management company for healthcare providers, today announced that Stan Nowak, Vice President of Consumer Experience at Aetna, a CVS Health Company, has officially joined its Board of Directors to aid in the company’s growth strategy and go-to-market initiatives. The appointment comes months after Censinet launched and announced its $7.8M Series A funding round co-led by HLM Venture Partners and Cedars-Sinai with participation from seed round investors Schooner Capital, LRVHealth and Excelerate Health Ventures.

Read Full Article >
October 8, 2019
Life Image and Graticule Announce Partnership to Help Biopharma Realize the Full Potential of Advanced Data in Real World Evidence Programs

Life Image, the world’s largest medical evidence network for clinical and imaging data, today announced a strategic partnership with Graticule, an advanced data firm that provides data subscriptions and advisory services. The partnership combines the market-leading capabilities of the two companies to help pharmaceutical and biotech companies accelerate drug development and post-market safety, effectiveness and label expansion.

Read Full Article >
September 26, 2019
Dr. Joanne Spadoro Joins First Light Diagnostics

First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Joanne Spadoro as its Vice President of R&D and Regulatory Affairs.

Read Full Article >